For the latest updates on the 2020/21 Flu Vaccination Service please visit the following links which will direct you to the PSNC website:
Public Health England, NHS England and NHS Improvement have issued a letter to general practices and community pharmacy contractors regarding the supply of quadrivalent flu vaccines. Manufacturers of quadrivalent flu vaccines have informed them that the delayed World Health Organization recommendation on vaccine strain has had an impact on their vaccine supply.
Sanofi Pasteur has indicated they plan to phase some of the deliveries of the inactivated quadrivalent influenza vaccines for those at risk and under 65 years, with some vaccines being delivered by the end of November 2019.
Contractors are therefore advised, if they have placed an order for quadrivalent influenza vaccines, to contact the relevant manufacturer or supplier to confirm delivery dates in order to plan effectively for the season.
Please see the link for a copy of the letter :
Given that the influenza vaccination service is now well-established, with multiple training providers, the North East LPCs have decided this year that we will NOT be commissioning any training. We have received the information below from four of the providers and we advise you to make direct contact with your provider of choice to book a place on their training session(s).
Their Newcastle face to face training (required every three years) will take place on Sunday 7Th July, 09:00 – 12:30. Venue to be confirmed.
Training costs £96.25 for members and £110 for non-members.
If you require online only training, this is priced at £27.50 for members and £30.50 for non-members.
All prices exclude VAT. More information is available at https://www.npa.co.uk/
Their Newcastle face to face training for those new to vaccination takes place on Sunday 22nd September, 09:00 – 13:30. Venue to be confirmed. More information at https://ecgtraining.co.uk/
Face to face training for experienced vaccinators in need of update training is Sunday 22nd September, 14:30 – 17:00. More information athttps://ecgtraining.co.uk/
The morning session is £110 and the afternoon session is £70. Both prices exclude VAT.
Skills in Healthcare
No details are available but there is an expression of interest form available on the website. Completion of the EOI does not commit you to attend or incur a charge. The form can be found at https://r1.dotmailer-surveys.
No information available at this time.
Further information is also available on the PSNC website. The direct link is https://psnc.org.uk/services-
Please do not miss out on your preferred location by delaying to book a place. Just to repeat, the LPCs will not be commissioning training this year.
You need to book directly with your preferred training provider.
Annual flu letter 2019/20
The Department of Health and Social Care, Public Health England and NHS England have jointly published a letter to provide further information on the national flu immunisation programme 2019/20.
A PSNC news story has been published to highlight this to contractors, click here
The LPC would like to remind contractors who are wishing to offer flu services next year to familiarise themselves with the NHS ENGLAND letter earlier this year and ensure they get their vaccine orders in on time to ensure they have the required vaccines.
Different wholesalers and manufactures have different deadlines however we are aware that Sequiris (Fluad and Flucelvax Tetra) have a deadline of 31st March for direct orders.
Please ensure that you get your orders in time to ensure you have a successful flu season.
Please also note that the new cell grown quadrivalent vaccine (QIVc), Flucelvax® Tetra is available to order from Seqirus. This vaccine can be used in both the over and under 65 risk groups, which may present a simpler solution to your vaccine ordering than trying to keep a stock of Fluad for the over 65s, and an egg-cultured quadrivalent vaccine for the under 65s. Flucelvax will be reimbursed by NHSE as per their letter
Update on vaccines for 2019/20 seasonal flu vaccination programme
This letter follows on from the letter sent by NHS England, Public Health England and the Department of Health and Social Care on 20 November 2018:
As stated in the previous letter, the vaccines recommended for the 2018/19 season continue to be recommended for the 2019/20 season. Both are currently licensed and available to order for use in the United Kingdom:
• The standard egg cultured quadrivalent inactivated vaccine (QIVe) will continue to be recommended for 18 to 64-year olds in clinical at-risk groups and other eligible groups, including frontline health and social care workers.
• The adjuvanted trivalent inactivated vaccine (aTIV) will continue to be recommended for individuals aged 65 years and over.
In addition, the cell grown quadrivalent vaccine (QIVc), Flucelvax® Tetra, is now licensed for use in the UK for patients aged nine years and upwards.
The Joint Committee on Vaccination and Immunisation (JCVI) considers that QIVc is equally suitable to:
• Quadrivalent inactivated vaccine (QIVe) for those aged 91 to 64 years in clinical at-risk groups and other eligible groups, including frontline health and social care workers.
Both QIVe and QIVc are preferable to standard egg based inactivated trivalent vaccines (TIVe). (1 All vaccines for those aged under 18 years will continue to be procured and supplied by Public Health England)
• Adjuvanted trivalent vaccine (aTIV) for individuals aged 65 years and over, which is preferable to standard egg based inactivated trivalent and quadrivalent vaccines
(TIVe/QIVe) on the grounds of both clinical and cost-effectiveness.
The high-dose trivalent vaccine (TIV-HD), which JCVI also advised as equally suitable for use in those aged 65 years and over, has now been licensed for use in the UK but has a significantly higher list price than the equally suitable vaccines. This vaccine will not be commissioned by NHS England or reimbursed for use in the NHS Influenza vaccination programme in 2019/20.
Providers should order currently licensed vaccines, aTIV, QIVe and QIVc for the 2019/20 season for their populations in eligible groups. These three recommended vaccines will be eligible for reimbursement by NHS England.
Advance letter about 2019-20 Flu season can be found here